Mode
Text Size
Log in / Sign up

Ebola

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ebola

15 trials tracked for Ebola: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 1604 citations.

15Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3 Phase 2 7 Phase 1 5
  1. Phase 3 Investigational Therapeutics for the Treatment of People With Ebola Virus Disease Completed · 1,604 cited
  2. Phase 3 Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo Completed · 91 cited
  3. Phase 3 A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants Completed
  4. Phase 2 A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants Completed
  5. Phase 2 Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study) Completed
  6. Phase 2 GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen Completed
Show 9 more trials
  1. Phase 2 Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Completed
  2. Phase 2 Partnership for Research on Ebola VACcinations Completed
  3. Phase 2 Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection Completed
  4. Phase 2 African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola Completed
  5. Phase 1 Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination Completed
  6. Phase 1 Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults Completed
  7. Phase 1 Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004) Completed
  8. Phase 1 Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) Completed
  9. Phase 1 A Study of a New Vaccine Against Two Types of Ebola Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Ebola

What interventions are modeled for stopping the Ebola epidemic?

Models show Ebola stops through isolation, expanding treatment beds, community engagement, and managing viral persistence in survivors.

Full answer →
How do social factors influence the spread of Ebola?

Social factors like human movement, community trust, and how people perceive risk directly change how fast Ebola spreads and how hard it is to stop.

Full answer →